Organoid Cultures Derived from Patients with Advanced Prostate Cancer





A
C
B
D
E
F
Figure2.MutationalLandscapeofPatient-DerivedProstateCancerOrganoidLines
(A)Quanti cationofnumberofnonsynonymoussingle-nucleotidevariations(SNV,pink)andinsertion-deletions(indel,orange)ineachorganoidsamplecomparedtoaveragetotalSNVandindelsofpublishedwhole-exomedatasets(green).Thelightbluelinerepresentstheaveragemutationsofthesevenorganoidlines.
(B)Thealterationrate(green:mutation,includingbothnonsynonymousSNV,blue:homozygousdeletion,red:ampli cation,gray:multiplealterations)ofgenesmutatedinthesevenorganoidsamplesinprostatecancerdatasets.
(legendcontinuedonnextpage)
4Cell159,1–12,September25,2014ª2014Elsevier

Inc.
from patients with advanced prostate, bladder, or breast cancer as well as...Regardless of whether the peptidome is derived from the tissue/microenvironment...
[6], advanced melanoma [11], prostate cancer [...from healthy donors and from patients with chronic...In DC cultures of four healthy donors, Freezing ...
热门文档